Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
N4BP2L1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MOG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CD1E - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZNF117 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
ADAM23 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HAP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CASQ2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RECQL5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
GNMT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CCDC170 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PTGDR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EPHX2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MMP27 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CFHR5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KNG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DMP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SIRPB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ODAM - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
H3F3AP4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on